Fully half to two-thirds of the weight lost on a GLP-1 agonist can be expected to be regained in the first year after stopping the drug
The female X chromosomes carry this
These drugs work, but they are prescription-only, expensive, and often come with gastrointestinal side effects that make long-term use tricky
Additionally, Tesamorelin has demonstrated efficacy in improving lipid profiles and reducing liver fat content in clinical studies, further underscoring its therapeutic potential in managing HIV-associated complications
This matters for any peptide, but it matters especially for compounds targeting the brain and endocrine system
The two main peptides that fulfill criteria for an incretin are the intestinal peptide glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP, also known as: glucose-dependent insulinotropic polypeptide)